Recent studies have demonstrated that bone marrow mesenchymal stem cells (BMSCs)
protect the injured neurons of spinal cord injury (SCI) from apoptosis while the underlying …

Mitochondrial dysfunction is a hallmark of secondary neuroinflammatory responses and
neuronal death in spinal cord injury (SCI). Even though mitochondria-based therapy is an …

Mitochondrial dysfunction in neurons has been implicated in hypoxia-ischemia-induced
brain injury. Although mesenchymal stem cell therapy has emerged as a novel treatment for …

Mesenchymal stromal cells (MSC) have excellent clinical potential and numerous properties
that ease its clinical translation. Mitochondria play a crucial role in energy metabolism …

The past decade has witnessed an upsurge in studies demonstrating mitochondrial transfer
as one of the emerging mechanisms through which mesenchymal stem cells (MSCs) can …

Mesenchymal stem cells (MSCs) transfer healthy mitochondria to damaged acceptor cells
via actin-based intercellular structures. In this study, we tested the hypothesis that MSCs …

Stroke-induced cerebral ischemia is a major cause of death and disability. The disruption of
blood flow results in neuronal and glial cell death leading to brain injury. Reperfusion …

Mesenchymal stromal/stem cells (MSCs) perform their therapeutic effects through various
mechanisms, including their ability to differentiate, producing different growth factors …

Acute ischemia stroke (AIS) is one of the leading causes of mortality and disability
worldwide, and its neurological impacts are devastating and permanent. There is no efficient …

Background Bone marrow-derived mesenchymal stem cell (BMSC) transplantation is
considered a promising therapeutic approach for bone defect repair. However, during the …